Table 1.
Lone MV | MV + CMIV | p-value | |
---|---|---|---|
N=109 | N=104 | ||
Age (years) | 65.6 ± 13.2 | 63.5 ± 11.8 | 0.21 |
Gender (female) | 53 (49%) | 57 (55%) | 0.41 |
NYHA Class III or IV | 84 (77.1%) | 74 (71%) | 0.35 |
Ejection Fraction (%) | 50 ± 14 | 51 ± 11 | 0.17 |
Renal failure | 12 (11%) | 1 (1%) | <0.01 |
Diabetes | 29 (27%) | 14 (14%) | 0.02 |
COPD | 41 (38%) | 20 (19%) | <0.01 |
Hyperlipidemia | 63 (58%) | 42 (40%) | 0.01 |
Previous MI | 30 (28%) | 4 (4%) | <0.01 |
Previous CVA | 20 (18%) | 5 (5%) | <0.01 |
Previous CABG | 22 (20%) | 3 (3%) | <0.01 |
Previous valve operation | 44 (40%) | 12 (12%) | <0.01 |
Predicted STS Operative Mortality (%) | 5.5 ± 5.2 | 2.5 ± 1.9 | <0.01 |
Abbreviations: CMIV, Cox-Maze IV; COPD, chronic obstructive pulmonary disease; CABG, coronary artery bypass graft; CVA, cerebral vascular accident; MI, myocardial infarction; MV, mitral valve; NYHA, New York Heart Association; STS, Society of Thoracic Surgeons.